Pertuzumab

ATC L01FD02 · 11 markets · 48 records

Pertuzumab 11 markets · 48 records Forms

ES 9 records · 3 strengths

AU 5 records · 5 strengths

  • 420 mginjectionPERJETA pertuzumab (rch) 30mg/mL concentrate injection vial also in ES·CN·TW unknown
  • 1,200 mginjectionPHESGO SC pertuzumab (rch) 1200mg and trastuzumab (rch) 600mg in 15mL solution for injection, vials also in ES·SG unknown
  • 600 mginjectionPHESGO SC pertuzumab (rch) 1200mg and trastuzumab (rch) 600mg in 15mL solution for injection, vials also in ES·SG unknown
  • 420 mg/14 mLinjectionPERJETA also in GB

Records without a stated strength · 1 PERJETA

GB 4 records · 3 strengths

CA 4 records · 3 strengths

CN 4 records · 1 strengths

  • 420 mginjection安赛珠帕妥珠单抗帕乐坦、帕捷特 also in ES·AU·TW

US 3 records · 3 strengths

SG 3 records · 3 strengths

TW 3 records · 2 strengths

Records without a stated strength · 1 Phesgo Solution for Subcutaneous Injection 1200/600 mg、賀雙妥皮下注射劑 1200/600毫克、賀雙妥皮下注射劑 600/600毫克

HK 3 records · 1 strengths

    Records without a stated strength · 1 PERJETA CONCENTRATE FOR SOLUTION FOR INFUSION 420MG/14ML、PHESGO SOLUTION FOR SUBCUTANEOUS INJECTION 1200MG/600MG IN 15ML

    EU 3 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 PERJETA、Phesgo、POHERDY

      MX 1 records · 1 strengths

        Records without a stated strength · 1 Phesgo

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.